Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
China Pharma Holdings Inc., through its subsidiary Hainan Helpson Medical and Biotechnology Co., Ltd., develops, manufactures, and markets prescription pharmaceutical products in China. Its portfolio includes generic drugs, first-to-market generics, and modern Traditional Chinese Medicines targeting high-incidence diseases like cardiovascular, CNS, infectious, and digestive conditions. Operating GMP-certified facilities, Helpson sells primarily to hospitals and pharmacies via a national distribution network, leveraging academic-driven promotion and regulatory compliance to maintain competitive positioning in China’s pharmaceutical market.
This description was generated via AI from an annual report. Updated about 1 year ago.